Reuters logo
BRIEF-Portola Pharmaceuticals enters loan agreement with Bristol-Myers Squibb and Pfizer
December 19, 2016 / 1:31 PM / in 10 months

BRIEF-Portola Pharmaceuticals enters loan agreement with Bristol-Myers Squibb and Pfizer

Dec 19 (Reuters) - Portola Pharmaceuticals Inc:

* Portola Pharmaceuticals enters into $50 million loan agreement with Bristol-Myers Squibb and Pfizer for continued development of andexxa (andexanet alfa)

* Portola Pharmaceuticals Inc - under terms of agreement, Bristol-Myers Squibb and Pfizer will each loan Portola $25 million

* Portola Pharmaceuticals Inc - under terms of agreement, principal and interest will be repaid primarily through royalties on andexxa commercial sales Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below